PlainRecalls
FDA Devices Moderate Class II Ongoing

Philips Connected Blood Glucose Meter, BGM 4; Model Number: TM0009;

Reported: March 12, 2025 Initiated: January 30, 2025 #Z-1270-2025

Product Description

Philips Connected Blood Glucose Meter, BGM 4; Model Number: TM0009;

Reason for Recall

Telcare, LLC has received customer complaints related to battery expansion/swelling for its Philips Connected Blood Glucose Meter (i.e., BGM 4 brand name) Monitoring System.. The issue was identified by post market surveillance data (customer complaints) - events of battery expansion/swelling and associated symptoms, e.g., leading to the device's removable back cover (battery port) to separate. If there is a loss of primary function of the device due to the described device defect, an immediate health consequence that may result is prolonged hypoglycemia or hyperglycemia due to delay in treatment, as the blood glucose measurement is not available to guide treatment. In a worst-case situation, there is potential for battery swelling to result in explosion of the battery and/ or device. Exposure to explosion, and subsequently projectiles from the explosion, may result in several immediate health consequences, including concussion, headache, dizziness, eye irritation, blurred vision, eye injury, and vision impairment.

Details

Recalling Firm
Telcare, LLC
Units Affected
34,764 units
Distribution
US Nationwide distribution.
Location
Concord, MA

Frequently Asked Questions

What product was recalled?
Philips Connected Blood Glucose Meter, BGM 4; Model Number: TM0009;. Recalled by Telcare, LLC. Units affected: 34,764 units.
Why was this product recalled?
Telcare, LLC has received customer complaints related to battery expansion/swelling for its Philips Connected Blood Glucose Meter (i.e., BGM 4 brand name) Monitoring System.. The issue was identified by post market surveillance data (customer complaints) - events of battery expansion/swelling and associated symptoms, e.g., leading to the device's removable back cover (battery port) to separate. If there is a loss of primary function of the device due to the described device defect, an immediate health consequence that may result is prolonged hypoglycemia or hyperglycemia due to delay in treatment, as the blood glucose measurement is not available to guide treatment. In a worst-case situation, there is potential for battery swelling to result in explosion of the battery and/ or device. Exposure to explosion, and subsequently projectiles from the explosion, may result in several immediate health consequences, including concussion, headache, dizziness, eye irritation, blurred vision, eye injury, and vision impairment.
Which agency issued this recall?
This recall was issued by the FDA Devices on March 12, 2025. Severity: Moderate. Recall number: Z-1270-2025.